Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,010 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.
Maruyama S, Kurasawa S, Hayashi T, Nangaku M, Narita I, Hirakata H, Tanabe K, Morita S, Tsubakihara Y, Imai E, Akizawa T; PREDICT Investigators. Maruyama S, et al. Among authors: tanabe k. Clin Exp Nephrol. 2023 Sep;27(9):757-766. doi: 10.1007/s10157-023-02362-w. Epub 2023 Jun 8. Clin Exp Nephrol. 2023. PMID: 37289335 Free PMC article. Clinical Trial.
Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.
Hayashi T, Maruyama S, Nangaku M, Narita I, Hirakata H, Tanabe K, Morita S, Tsubakihara Y, Imai E, Akizawa T; PREDICT Investigators. Hayashi T, et al. Among authors: tanabe k. Clin J Am Soc Nephrol. 2020 May 7;15(5):608-615. doi: 10.2215/CJN.08900719. Epub 2020 Apr 3. Clin J Am Soc Nephrol. 2020. PMID: 32245781 Free PMC article. Clinical Trial.
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan.
Hayashi T, Kato H, Tanabe K, Nangaku M, Hirakata H, Wada T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I. Hayashi T, et al. Among authors: tanabe k. Clin Exp Nephrol. 2021 Feb;25(2):110-119. doi: 10.1007/s10157-020-01969-7. Epub 2020 Sep 19. Clin Exp Nephrol. 2021. PMID: 32949295 Free PMC article.
Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE).
Yamashita S, Arai H, Bujo H, Masuda D, Ohama T, Ishibashi T, Yanagi K, Doi Y, Nakagawa S, Yamashiro K, Tanabe K, Kita T, Matsuzaki M, Saito Y, Fukushima M, Matsuzawa Y; PROSPECTIVE Study Group. Yamashita S, et al. Among authors: tanabe k. J Atheroscler Thromb. 2021 Feb 1;28(2):103-123. doi: 10.5551/jat.55327. Epub 2020 Apr 24. J Atheroscler Thromb. 2021. PMID: 32336695 Free PMC article. Clinical Trial.
Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT.
Arai H, Bujo H, Masuda D, Ishibashi T, Nakagawa S, Tanabe K, Kagimura T, Kang HJ, Kim MH, Sung J, Kim SH, Kim CH, Park JE, Ge J, Oh BH, Kita T, Saito Y, Fukushima M, Matsuzawa Y, Yamashita S. Arai H, et al. Among authors: tanabe k. J Atheroscler Thromb. 2022 Jun 1;29(6):850-865. doi: 10.5551/jat.62821. Epub 2021 Apr 18. J Atheroscler Thromb. 2022. PMID: 33867420 Free PMC article. Clinical Trial.
Prospective Registry of Embolization of Intracranial Aneurysms Using HydroSoft Coils: Results of the Japanese HydroSoft Registry.
Imamura H, Sakai N, Ito Y, Sakai C, Hyodo A, Miyachi S, Matsumaru Y, Yoshimura S, Abe T, Yamagami H, Hayakawa M, Sato H, Fujinaka T, Tanabe K; JHSR Collaborators. Imamura H, et al. Among authors: tanabe k. World Neurosurg. 2019 Jul;127:e631-e637. doi: 10.1016/j.wneu.2019.03.234. Epub 2019 Apr 1. World Neurosurg. 2019. PMID: 30947007
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial.
Asano T, Tanigaki T, Hoshino M, Yasunaga M, Nonaka H, Emori H, Katagiri Y, Miyazaki Y, Sotomi Y, Kogame N, Kuramitsu S, Saito A, Miyata K, Takaoka Y, Kanie T, Yamasaki M, Yoshino K, Wakabayashi N, Ouchi K, Kodama H, Shiina Y, Tamaki R, Nishihata Y, Masuda K, Suzuki T, Reiber JHC, Okamura T, Higuchi Y, Kakuta T, Misumi H, Abe K, Komiyama N, Tanabe K, Matsuo H, Qfr Investigators OBOTD. Asano T, et al. Among authors: tanabe k. EuroIntervention. 2024 May 10;20(9):561-570. doi: 10.4244/EIJ-D-23-00674. EuroIntervention. 2024. PMID: 38726719 Clinical Trial.
3,010 results